Operating Income (Loss) in USD of MESA LABORATORIES INC /CO/ from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
MESA LABORATORIES INC /CO/ quarterly and annual Operating Income (Loss) history and change rate from Q4 2010 to Q3 2025.
  • MESA LABORATORIES INC /CO/ Operating Income (Loss) for the quarter ending 30 Sep 2025 was $4,724,000, a 35% increase year-over-year.
  • MESA LABORATORIES INC /CO/ Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $15,036,000.
  • MESA LABORATORIES INC /CO/ annual Operating Income (Loss) for 2024 was $16,336,000.
  • MESA LABORATORIES INC /CO/ annual Operating Income (Loss) for 2023 was $272,075,000, a 8295% decline from 2022.
  • MESA LABORATORIES INC /CO/ annual Operating Income (Loss) for 2022 was $3,320,000, a 29% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

MESA LABORATORIES INC /CO/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,036,000 $4,724,000 +$1,216,000 +35% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q2
Q2 2025 $13,820,000 $3,064,000 -$2,516,000 -45% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q1
Q1 2025 $16,336,000 $1,469,000 +$272,753,000 01 Jan 2025 31 Mar 2025 10-K 28 May 2025 2025 FY
Q4 2024 $256,417,000 $5,779,000 +$5,846,000 01 Oct 2024 31 Dec 2024 10-Q 04 Feb 2025 2025 Q3
Q3 2024 $262,263,000 $3,508,000 +$3,568,000 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q2
Q2 2024 $265,831,000 $5,580,000 +$6,244,000 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q1
Q1 2024 $272,075,000 $271,284,000 -$271,801,000 -52573% 01 Jan 2024 31 Mar 2024 10-K 28 May 2025 2025 FY
Q4 2023 $274,000 $67,000 -$3,469,000 -102% 01 Oct 2023 31 Dec 2023 10-Q 04 Feb 2025 2025 Q3
Q3 2023 $3,195,000 $60,000 -$4,055,000 -102% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2025 Q2
Q2 2023 $7,250,000 $664,000 +$3,930,000 +86% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2025 Q1
Q1 2023 $3,320,000 $517,000 +$627,000 01 Jan 2023 31 Mar 2023 10-K 28 May 2025 2025 FY
Q4 2022 $2,693,000 $3,402,000 +$5,914,000 01 Oct 2022 31 Dec 2022 10-Q 05 Feb 2024 2024 Q3
Q3 2022 $3,221,000 $3,995,000 -$206,000 -4.9% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2024 Q2
Q2 2022 $3,015,000 $4,594,000 -$7,717,000 -247% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2024 Q1
Q1 2022 $4,702,000 $110,000 -$4,406,000 -103% 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2024 2024 FY
Q4 2021 $9,108,000 $2,512,000 -$2,534,000 -11518% 01 Oct 2021 31 Dec 2021 10-Q 06 Feb 2023 2023 Q3
Q3 2021 $11,642,000 $4,201,000 -$269,000 -6% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2023 Q2
Q2 2021 $11,911,000 $3,123,000 -$447,000 -13% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2023 Q1
Q1 2021 $12,358,000 $4,296,000 +$3,204,000 +293% 01 Jan 2021 31 Mar 2021 10-K 30 May 2023 2023 FY
Q4 2020 $9,154,000 $22,000 +$3,277,000 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022 2022 Q3
Q3 2020 $5,877,000 $4,470,000 -$224,000 -4.8% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2022 Q2
Q2 2020 $6,101,000 $3,570,000 -$1,822,000 -34% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2022 Q1
Q1 2020 $7,923,000 $1,092,000 -$1,467,000 -57% 01 Jan 2020 31 Mar 2020 10-K 31 May 2022 2022 FY
Q4 2019 $9,390,000 $3,255,000 -$4,575,000 -347% 01 Oct 2019 31 Dec 2019 10-Q 03 Feb 2021 2020 Q3
Q3 2019 $13,965,000 $4,694,000 +$3,556,000 +312% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q2
Q2 2019 $10,409,000 $5,392,000 +$628,000 +13% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q1
Q1 2019 $9,781,000 $2,559,000 -$4,082,000 -61% 01 Jan 2019 31 Mar 2019 10-K 01 Jun 2021 2021 FY
Q4 2018 $13,863,000 $1,320,000 +$11,408,000 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q3 2018 $2,455,000 $1,138,000 -$2,510,000 -69% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2020 Q2
Q2 2018 $4,965,000 $4,764,000 +$2,782,000 +140% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2020 Q1
Q1 2018 $2,183,000 $6,641,000 +$1,301,000 +24% 01 Jan 2018 31 Mar 2018 10-K 01 Jun 2020 2020 FY
Q4 2017 $882,000 $10,088,000 -$14,474,000 -330% 01 Oct 2017 31 Dec 2017 10-Q 04 Feb 2019 2019 Q3
Q3 2017 $15,356,000 $3,648,000 -$364,000 -9.1% 01 Jul 2017 30 Sep 2017 10-Q 31 Oct 2018 2019 Q2
Q2 2017 $15,720,000 $1,982,000 -$593,000 -23% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2019 Q1
Q1 2017 $16,313,000 $5,340,000 -$503,000 -8.6% 01 Jan 2017 31 Mar 2017 10-K 03 Jun 2019 2019 FY
Q4 2016 $16,816,000 $4,386,000 +$554,000 +14% 01 Oct 2016 31 Dec 2016 10-Q 06 Feb 2018 2018 Q3
Q3 2016 $16,262,000 $4,012,000 +$1,006,000 +33% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2018 Q2
Q2 2016 $15,256,000 $2,575,000 -$1,067,000 -29% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2018 Q1
Q1 2016 $16,323,000 $5,843,000 +$1,642,000 +39% 01 Jan 2016 31 Mar 2016 10-K 05 Jun 2018 2018 FY
Q4 2015 $14,681,000 $3,832,000 +$124,000 +3.3% 01 Oct 2015 31 Dec 2015 10-Q 06 Feb 2017 2017 Q3
Q3 2015 $14,557,000 $3,006,000 -$1,894,000 -39% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2017 Q2
Q2 2015 $16,451,000 $3,642,000 +$587,000 +19% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2017 Q1
Q1 2015 $15,864,000 $4,201,000 +$780,000 +23% 01 Jan 2015 31 Mar 2015 10-K 07 Jun 2017 2017 FY
Q4 2014 $15,084,000 $3,708,000 +$902,000 +32% 01 Oct 2014 31 Dec 2014 10-Q 04 Feb 2016 2016 Q3
Q3 2014 $14,182,000 $4,900,000 +$2,385,000 +95% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015 2016 Q2
Q2 2014 $11,797,000 $3,055,000 +$12,000 +0.39% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015 2016 Q1
Q1 2014 $11,785,000 $3,421,000 -$512,000 -13% 01 Jan 2014 31 Mar 2014 10-K 06 Jun 2016 2016 FY
Q4 2013 $12,297,000 $2,806,000 +$342,000 +14% 01 Oct 2013 31 Dec 2013 10-Q 02 Feb 2015 2015 Q3
Q3 2013 $11,955,000 $2,515,000 -$973,000 -28% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2015 Q2
Q2 2013 $12,928,000 $3,043,000 -$176,000 -5.5% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2015 Q1
Q1 2013 $13,104,000 $3,933,000 +$597,000 +18% 01 Jan 2013 31 Mar 2013 10-K 03 Jun 2015 2015 FY
Q4 2012 $12,507,000 $2,464,000 -$698,000 -22% 01 Oct 2012 31 Dec 2012 10-Q 05 Feb 2014 2013 Q3
Q3 2012 $13,205,000 $3,488,000 +$202,000 +6.1% 01 Jul 2012 30 Sep 2012 10-Q 05 Nov 2013 2013 Q2
Q2 2012 $13,003,000 $3,219,000 +$526,000 +20% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013 2013 Q1
Q1 2012 $12,477,000 $3,336,000 01 Jan 2012 31 Mar 2012 10-K 04 Jun 2014 2014 FY
Q4 2011 $3,162,000 +$1,160,000 +58% 01 Oct 2011 31 Dec 2011 10-Q 08 Feb 2013 2012 Q3
Q3 2011 $3,286,000 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q2
Q2 2011 $2,693,000 01 Apr 2011 30 Jun 2011 10-Q 10 Aug 2012 2012 Q1
Q4 2010 $2,002,000 01 Oct 2010 31 Dec 2010 10-Q 10 Feb 2012 2011 Q3

MESA LABORATORIES INC /CO/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $16,336,000 +$288,411,000 01 Apr 2024 31 Mar 2025 10-K 28 May 2025 2025 FY
2023 $272,075,000 -$275,395,000 -8295% 01 Apr 2023 31 Mar 2024 10-K 28 May 2025 2025 FY
2022 $3,320,000 -$1,382,000 -29% 01 Apr 2022 31 Mar 2023 10-K 28 May 2025 2025 FY
2021 $4,702,000 -$7,656,000 -62% 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2024 2024 FY
2020 $12,358,000 +$4,435,000 +56% 01 Apr 2020 31 Mar 2021 10-K 30 May 2023 2023 FY
2019 $7,923,000 -$1,858,000 -19% 01 Apr 2019 31 Mar 2020 10-K 31 May 2022 2022 FY
2018 $9,781,000 +$7,598,000 +348% 01 Apr 2018 31 Mar 2019 10-K 01 Jun 2021 2021 FY
2017 $2,183,000 -$14,130,000 -87% 01 Apr 2017 31 Mar 2018 10-K 01 Jun 2020 2020 FY
2016 $16,313,000 -$10,000 -0.06% 01 Apr 2016 31 Mar 2017 10-K 03 Jun 2019 2019 FY
2015 $16,323,000 +$459,000 +2.9% 01 Apr 2015 31 Mar 2016 10-K 05 Jun 2018 2018 FY
2014 $15,864,000 +$4,079,000 +35% 01 Apr 2014 31 Mar 2015 10-K 07 Jun 2017 2017 FY
2013 $11,785,000 -$1,319,000 -10% 01 Apr 2013 31 Mar 2014 10-K 06 Jun 2016 2016 FY
2012 $13,104,000 +$627,000 +5% 01 Apr 2012 31 Mar 2013 10-K 03 Jun 2015 2015 FY
2011 $12,477,000 +$2,613,000 +26% 01 Apr 2011 31 Mar 2012 10-K 04 Jun 2014 2014 FY
2010 $9,864,000 01 Apr 2010 31 Mar 2011 10-K 06 Jun 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.